Quantum-Si Inc at Canaccord Genuity Growth Conference Transcript
I'm excited to cover life science tools and diagnostics for Canaccord. Pleased to have fun -- I mean, Quantum Si here with us today. Quantum Si is the first company to launch commercially a next-generation protein sequencer. And with us from the company, we have Jeff Hawkins, the CEO; and Jeff Keyes, the new CFO. So thanks, guys, for joining us today.
Thank you.
So Jeff Hawkins, you had earnings Monday morning, this Monday morning. Interesting updates. You had a nice launch in the first quarter with Platinum, which is your sequencer. A few installs we estimate. But I mean, this sounds like start, I think, like a similar stable quarter. We wanted to see more of like a growth trajectory.
Questions & Answers
But I mean, would you tell us of what happened in the past six months, I guess, in that first
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |